Go Pro

Revvity (NYSE:RVTY) Sets New 52-Week High - Here's What Happened

Revvity logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Revvity shares reached a new 52-week high of $131.09, last trading at $129.91 versus a prior close of $126.59.
  • Analysts remain cautious, with three Buy ratings and thirteen Holds; the consensus rating is Hold with an average price target of $110.58, below the current share price.
  • Revvity exceeded quarterly expectations, reporting $1.41 in EPS and $729.69 million in revenue, while issuing fiscal 2026 EPS guidance of $5.30–$5.40. The company also declared a quarterly dividend of $0.07 per share.
  • MarketBeat previews the top five stocks to own by October 1st.

Revvity Inc. (NYSE:RVTY - Get Free Report) shares hit a new 52-week high on Wednesday . The stock traded as high as $131.09 and last traded at $129.91, with a volume of 100609 shares changing hands. The stock had previously closed at $126.59.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on RVTY. Zacks Research raised Revvity from a "strong sell" rating to a "hold" rating in a report on Tuesday, August 4th. Stifel Nicolaus cut their price objective on shares of Revvity from $110.00 to $100.00 and set a "hold" rating for the company in a research report on Wednesday, May 6th. Barclays lifted their price target on shares of Revvity from $95.00 to $105.00 and gave the company an "equal weight" rating in a report on Thursday, May 7th. Wall Street Zen lowered shares of Revvity from a "buy" rating to a "hold" rating in a report on Sunday, August 16th. Finally, Royal Bank Of Canada assumed coverage on Revvity in a research report on Tuesday. They set a "sector perform" rating and a $135.00 price objective for the company. Three analysts have rated the stock with a Buy rating and thirteen have given a Hold rating to the company. According to MarketBeat, the company presently has an average rating of "Hold" and an average target price of $110.58.

View Our Latest Research Report on Revvity

Revvity Stock Performance

The company has a market capitalization of $14.47 billion, a PE ratio of 61.74, a PEG ratio of 2.34 and a beta of 1.09. The company has a quick ratio of 1.50, a current ratio of 1.80 and a debt-to-equity ratio of 0.36. The business has a 50 day simple moving average of $115.22 and a 200 day simple moving average of $101.55.

Revvity (NYSE:RVTY - Get Free Report) last issued its quarterly earnings results on Tuesday, August 4th. The company reported $1.41 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.21 by $0.20. The company had revenue of $729.69 million for the quarter, compared to the consensus estimate of $702.96 million. Revvity had a return on equity of 8.34% and a net margin of 8.16%.Revvity's revenue for the quarter was down 1.3% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.18 earnings per share. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. Equities research analysts predict that Revvity Inc. will post 5.36 EPS for the current fiscal year.

Revvity Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Friday, October 23rd will be given a dividend of $0.07 per share. The ex-dividend date of this dividend is Friday, October 23rd. This represents a $0.28 annualized dividend and a yield of 0.2%. Revvity's payout ratio is 13.33%.

Institutional Trading of Revvity

Hedge funds have recently made changes to their positions in the company. California State Teachers Retirement System boosted its stake in shares of Revvity by 10,607.8% during the second quarter. California State Teachers Retirement System now owns 14,328,063 shares of the company's stock valued at $1,594,140,000 after acquiring an additional 14,194,254 shares during the last quarter. EdgePoint Investment Group Inc. grew its holdings in Revvity by 3.1% in the 1st quarter. EdgePoint Investment Group Inc. now owns 8,800,863 shares of the company's stock valued at $771,044,000 after buying an additional 265,204 shares during the period. Jupiter Topco LLC acquired a new position in shares of Revvity during the 2nd quarter valued at about $961,017,000. Price T Rowe Associates Inc. MD boosted its position in shares of Revvity by 5.3% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 8,606,637 shares of the company's stock worth $832,693,000 after acquiring an additional 434,570 shares during the last quarter. Finally, Janus Henderson Group PLC grew its holdings in Revvity by 2.3% in the first quarter. Janus Henderson Group PLC now owns 8,348,127 shares of the company's stock valued at $731,386,000 after purchasing an additional 186,956 shares during the period. Institutional investors and hedge funds own 86.65% of the company's stock.

Revvity Company Profile

(Get Free Report)

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Revvity Right Now?

Before you consider Revvity, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Revvity wasn't on the list.

While Revvity currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines